Genmab | GEN - الدين





الدين تغيير تاريخ
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
Almirall EUR 356.11M 13.25M 2026-06
Amarin USD 0 0 2025-03
Amgen USD 57.3B 19M 2026-06
argenx SE USD 47M 160K 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Bayer EUR 36.45B 2.93B 2025-12
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Demant DKK 20.28B 706M 2026-06
Exelixis USD 162.2M 3.73M 2026-09
Fresenius Medical Care EUR 10.89B 76.86M 2026-09
Genmab DKK 5.35B 5.2B 2026-03
GlaxoSmithKline GBP 18.24B 818M 2026-06
GN Store Nord DKK 10.5B 52M 2026-09
GRIFOLS EUR 9.24B 723M 2026-09
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Insmed USD 544.86M 180.93M 2026-09
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.04B 86M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
UCB EUR 3.03B 12M 2024-12